Otonomy to Present at the Raymond James Life Sciences and MedTech Conference

Back to Jobs

SAN DIEGO , June 12, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that David A. Weber , Ph.D., president and chief executive officer, will present at the Raymond James

Apply Now